Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,629 | 387 | 98.6% |
| Education | $81.94 | 11 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $757.53 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $485.27 | 32 | $0 (2021) |
| Amgen Inc. | $463.95 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $401.94 | 32 | $0 (2023) |
| PFIZER INC. | $275.58 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $254.59 | 15 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $235.92 | 16 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $230.77 | 23 | $0 (2018) |
| Lilly USA, LLC | $204.71 | 16 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $192.86 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258.38 | 12 | Organogenesis Inc. ($69.29) |
| 2023 | $330.64 | 22 | Amgen Inc. ($163.56) |
| 2022 | $277.39 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($130.77) |
| 2021 | $372.11 | 21 | Novo Nordisk Inc ($100.85) |
| 2020 | $195.78 | 15 | Arbor Pharmaceuticals, Inc. ($29.07) |
| 2019 | $985.33 | 72 | Novo Nordisk Inc ($224.04) |
| 2018 | $1,227 | 82 | GlaxoSmithKline, LLC. ($157.83) |
| 2017 | $2,064 | 164 | AstraZeneca Pharmaceuticals LP ($219.57) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $69.29 | General |
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Obesity | ||||||
| 07/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Diabetes Care | ||||||
| 06/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes Care | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Inflammation | ||||||
| 05/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Obesity | ||||||
| 04/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 03/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: VACCINES | ||||||
| 01/05/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GALLSTONES | ||||||
| 01/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 12/19/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Inflammation | ||||||
| 12/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Inflammation | ||||||
| 11/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: VACCINES | ||||||
| 10/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 10/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Obesity | ||||||
| 10/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Inflammation | ||||||
| 09/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 09/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Diabetes | ||||||
| 09/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Inflammation | ||||||
| 09/08/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,288 | 3,111 | $287,619 | $102,317 |
| 2022 | 33 | 2,264 | 3,007 | $260,112 | $88,616 |
| 2021 | 36 | 2,393 | 3,268 | $266,485 | $97,660 |
| 2020 | 32 | 2,776 | 3,829 | $293,967 | $94,480 |
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 3 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 65 | 87 | $2,175 | $725.74 | 33.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 61 | 72 | $2,880 | $552.32 | 19.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 23 | 25 | $1,125 | $452.93 | 40.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 19 | 27 | $1,215 | $390.88 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 40 | $2,240 | $376.54 | 16.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 17 | 17 | $680.00 | $357.97 | 52.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 56 | 60 | $1,200 | $337.79 | 28.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 53 | 57 | $1,995 | $291.21 | 14.6% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 15 | 20 | $940.00 | $268.67 | 28.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 15 | 15 | $525.00 | $177.97 | 33.9% |
| 84550 | Uric acid level, blood | Office | 2022 | 29 | 40 | $1,200 | $174.19 | 14.5% |
| 83550 | Iron binding capacity | Office | 2022 | 13 | 18 | $540.00 | $155.10 | 28.7% |
| 83540 | Iron level | Office | 2022 | 13 | 18 | $504.00 | $114.78 | 22.8% |
| 80076 | Liver function blood test panel | Office | 2022 | 11 | 14 | $420.00 | $113.18 | 26.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 19 | 25 | $400.00 | $71.48 | 17.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 11 | $176.00 | $24.38 | 13.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 158 | 273 | $75,130 | $35,006 | 46.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 214 | 306 | $64,260 | $26,806 | 41.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 206 | 262 | $13,550 | $4,402 | 32.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 218 | 280 | $12,600 | $3,749 | 29.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 17 | 17 | $9,367 | $3,203 | 34.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 212 | 267 | $12,975 | $2,820 | 21.7% |
| 82306 | Vitamin d-3 level | Office | 2021 | 70 | 90 | $6,750 | $2,664 | 39.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 32 | 32 | $2,560 | $2,088 | 81.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 117 | 201 | $7,035 | $1,952 | 27.7% |
About Dr. Robert Johnson, MD
Dr. Robert Johnson, MD is a Family Medicine healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982780722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Johnson, MD has received a total of $5,711 in payments from pharmaceutical and medical device companies, with $258.38 received in 2024. These payments were reported across 398 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,629).
As a Medicare-enrolled provider, Johnson has provided services to 9,721 Medicare beneficiaries, totaling 13,215 services with total Medicare billing of $383,073. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Leland, NC
- Active Since 10/27/2006
- Last Updated 07/16/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982780722
Products in Payments
- FARXIGA (Drug) $423.64
- Ozempic (Drug) $262.56
- JARDIANCE (Drug) $255.17
- Otezla (Drug) $240.32
- JANUVIA (Drug) $185.15
- XIFAXAN (Drug) $168.32
- Xyrem (Drug) $165.94
- Saxenda (Drug) $157.25
- ANORO (Drug) $136.23
- OFIRMEV (Drug) $132.46
- Belviq (Drug) $131.92
- CONTRAVE (Drug) $121.11
- Trintellix (Drug) $115.84
- Prolia (Biological) $115.80
- Vascepa (Drug) $114.38
- Horizant (Drug) $97.12
- SOLIQUA (Drug) $94.01
- Wegovy (Drug) $88.40
- Victoza (Drug) $85.45
- TOUJEO (Drug) $83.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Leland
Kira Alatar, Md, MD
Family Medicine — Payments: $6,634
Dr. Anette Bodoky, M.d, M.D
Family Medicine — Payments: $3,461
Dr. Lekeshia Jarrett, Md, MD
Family Medicine — Payments: $2,607
Gloria Vreeland, M.d, M.D
Family Medicine — Payments: $1,629
Rajya Atluri, M.d, M.D
Family Medicine — Payments: $1,041
Joana Carnahan, D.o, D.O
Family Medicine — Payments: $994.40